Manufacturing

Meg Rivers is the former senior editor for 

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Articles

Global supply chain experts examine implications of the DSCSA as well as topical considerations around the EU's FMD in this serialization video series ft. manufacturing, packaging, software, and regulatory experts.

Serialization on a Global Scale: Deep Dive into the US DSCSA and EU FMD – Manufacturing | Part 1

GenScript’s new gene synthesis center in Piscataway, NJ, is highly automated to accelerate production time and increase supply chain resiliency for biopharma and synthetic biology.

GenScript Opens New Gene Synthesis Center in New Jersey

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Machine and material innovations yield more efficient, sustainable processes for pharmaceutical packaging, including vaccine vials. 

Labeling Efficiently

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Best practices help mitigate generic drug shortages.

Meeting Supply and Training Challenges 

The second part of the CPhI Annual Report has predicted an accelerated rate of change in pharma manufacturing and supply over the coming five years.

CPhI Report Predicts Accelerated Rate of Change in Pharma Manufacturing and Supply Over Next Five Years

Advanced powder testing is a useful tool to differentiate materials and optimize the supply chain.

Building Robust Specifications Using Powder Testing

CPhI is set to provide the pharma community with an ideal platform to engage with new value chain stakeholders post-COVID.

Rethinking, Recalibrating, and Retooling

According to Charles River Laboratories, when asked how long it takes for a drug to be developed and approved for market in the United States, only 10% of 1,500 Americans polled correctly estimated that it takes between 10 and 15 years.

Only 10% of Americans Understand the Drug Development Timeline, Survey Finds

Low- and middle-income countries are at the greatest risk of receiving substandard and falsified COVID-19 vaccines.

The Real Danger of Substandard and Counterfeit COVID-19 Vaccines

The COVID-19 pandemic has further impacted ongoing drug shortage issues; essential action is needed to avoid repeating previous mistakes.

Supply Chain